Tumour necrosis factor superfamily cytokines and the pathogenesis of inflammatory osteolysis

Annals of the Rheumatic Diseases

Volumn 61, Issue SUPPL. 2, 2002, Pages

  Lam, J ^a   Abu Amer, Y ^a   Nelson, C A ^a   Fremont, D H ^a   Ross, F P ^a   Teitelbaum, S L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR;

BONE ATROPHY; CELL DIFFERENTIATION; CONFERENCE PAPER; CRYSTAL STRUCTURE; CYTOKINE PRODUCTION; HUMAN; INFLAMMATORY DISEASE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE;

EID: 0036839607     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.suppl_2.ii82     Document Type: Conference Paper

References (13)

1. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000;289:1504-8.
2. 3 integrins are osteosclerotic due to dysfunctional osteoclasts. J Clin Invest 2000;105:433-40.
3. Blair HC, Teitelbaum SL, Ghiselli R, Gluck S. Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 1989;245:855-7.
4. Abu-Amer Y, Ross FP Schlesinger P, Tondravi MM, Teitelbaum SL. Substrate recognition by osteoclast precursors induces c-src/microtubule association. J Cell Biol 1997;137:247-58.
5. Abu-Amer Y, Teitelbaum SL, Schlesinger P, Ross FP. Expression and regulation of RAB3 proteins in osteoclasts and their precursors. J Bone Miner Res 1999;14:1855-60.
6. Silver IA, Murrilis RJ, Etherington DJ. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 19881;175:266.
7. Blair HC, Kahn AJ, Crouch EC, Jeffrey JJ, Teitelbaum SL. Isolated osteoclasts resorb the organic and inorganic components of bone. J Cell Biol 1986;102:1164-72.
8. Li YP, Chen W, Liang Y, Li E, Stashenko P. Atpói-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nature Genet 1999;23:447-51.
9. Lacey DL, Timms E, Tan H-L, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-76.
10. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL. TNFα-induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 2000;106:1481-8.
11. Abu-Amer Y, Ross FP, Edwards J, Teitelbaum SL. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its p55 receptor. J Clin Invest 1997;100:1557-65.
12. Abu-Amer Y, Erdmann J, Kollias G, Ross FP, Teitelbaum SL. Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J Biol Chem 2000;275:27307-10.
13. Lam J, Nelson CA, Ross FP, Teitelbaum SL, Fremont DL. Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity. J Clin Invest 2001;108:971-9.